Literature DB >> 17535074

Pharmacokinetic-pharmacodynamic modelling of ketamine in six neurotraumatised intensive care patients.

Youssef Hijazi1, Carole Bodonian, François Salord, Françoise Bressolle, Roselyne Boulieu.   

Abstract

Entities:  

Year:  2003        PMID: 17535074     DOI: 10.2165/00044011-200323090-00007

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  16 in total

1.  [Recovery in neurosurgery].

Authors:  P Ravussin; J Marty; G Boulard
Journal:  Ann Fr Anesth Reanim       Date:  1992

2.  Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine.

Authors:  H Ihmsen; G Geisslinger; J Schüttler
Journal:  Clin Pharmacol Ther       Date:  2001-11       Impact factor: 6.875

Review 3.  Sedation assessment in critically ill adults.

Authors:  J W Devlin; G L Fraser; S Kanji; R R Riker
Journal:  Ann Pharmacother       Date:  2001-12       Impact factor: 3.154

4.  HPLC determination of ketamine, norketamine, and dehydronorketamine in plasma with a high-purity reversed-phase sorbent.

Authors:  S Bolze; R Boulieu
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

5.  Pharmacokinetics and haemodynamics of ketamine in intensive care patients with brain or spinal cord injury.

Authors:  Y Hijazi; C Bodonian; M Bolon; F Salord; R Boulieu
Journal:  Br J Anaesth       Date:  2003-02       Impact factor: 9.166

6.  Pharmacokinetics and analgesic effect of ketamine in man.

Authors:  J A Clements; W S Nimmo
Journal:  Br J Anaesth       Date:  1981-01       Impact factor: 9.166

7.  Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method.

Authors:  G Geisslinger; W Hering; P Thomann; R Knoll; H D Kamp; K Brune
Journal:  Br J Anaesth       Date:  1993-06       Impact factor: 9.166

8.  Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man.

Authors:  J Schüttler; D R Stanski; P F White; A J Trevor; Y Horai; D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

9.  Ketamine prevents ischemic neuronal injury.

Authors:  F W Marcoux; J E Goodrich; M A Dominick
Journal:  Brain Res       Date:  1988-06-14       Impact factor: 3.252

10.  The effect of ketamine on intracranial pressure during haemorrhagic shock under the conditions of both spontaneous breathing and controlled ventilation.

Authors:  E Pfenninger; A Grünert; I Bowdler; J Kilian
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

View more
  1 in total

1.  Development of a sublingual/oral formulation of ketamine for use in neuropathic pain: Preliminary findings from a three-way randomized, crossover study.

Authors:  Chui Chong; Stephan A Schug; Madhu Page-Sharp; Barry Jenkins; Kenneth F Ilett
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.